Contact us
Back

Impact of Brazilian tax reforms on the life sciences sector

Share:

The highly complicated tax system is one of the main hindrances for Brazilian economic growth and encouraging foreign direct investment. Several attempts have been made by the past and present governments to pass tax reform bills that simplify the system and create a suitable environment for foreign investment and start-up companies.
Most recently, the government tabled a tax reform bill (PL no. 3.887 / 2020) – “Contribuição sobre Bens e Serviços” – in English “Contribution on Goods and Services – CBS” or “IVA – Federal”.

The aim of this latest reform bill is to amalgamate the existing Programa de Integração Social (PIS) and Contribuição para Financiamento da Seguridade Social (COFINS) taxes.

Current PIS/COFINS legislation

Current PIS/COFINS legislation PIS and COFINS are federal taxes charged on gross revenue – calculated and reported on a monthly basis as part of SPED EFD Contributions submission.

These taxes are determined using one of two tax regimes – Non-Cumulative or Cumulative:

Non – Cumulative Tax Regime:

In this regime, taxpayers cannot claim PIS/COFINS credits and it is applied to:
  • Companies that cannot generate input PIS/COFINS credits through their procurement process such as financial institutions
  • Companies in industries like telecommunications, transportation service providers, and software consulting follow this regime
  • For specific activities such as importation, companies can claim 9.25% in tax credits and special regimes are applied to promote particular industries like automotive, pharmaceuticals, and energy to boost the Brazilian economy.
This regime is applied to companies that calculate their corporate income tax under Lucro presumido (presumed profit method).

Cumulative Tax Regime:

In this regime, taxpayers cannot claim PIS/COFINS credits and it is applied to:
  • Companies that cannot generate input PIS/COFINS credits through their procurement process such as financial institutions
  • Companies in industries like telecommunications, transportation service providers, and software consulting follow this regime
  • For specific activities such as importation, companies can claim 9.25% in tax credits and special regimes are applied to promote particular industries like automotive, pharmaceuticals, and energy to boost the Brazilian economy.
This regime is applied to companies that calculate their corporate income tax under Lucro presumido (presumed profit method).

Impact of existing legislation on life sciences

Under law 10.865/04, the pharmaceutical and consumer healthcare industries enjoy special regime benefits to allow them to operate under the ‘single-phase regime’. This means:
  • Non-cumulative regime rules apply when purchasing raw materials, components, and consumables for the manufacturing process
  • The cumulative regime applies when pharmaceutical companies sell finished products to clients – under special rates
  • Finished products are exempt from PIS/COFINS tax in subsequent commercial transactions
In Life Sciences, finished products are charged at different PIS/COFINS tax rates. This is based on the classification of products into three categories: Positive, Negative, and Neutral..

Positive products:

  • Type of products: Prescription and Controlled drug substances
  • Single-phase regime with 2.1% PIS and 9.9% COFINS
  • The calculation is based on lucro presumido & Zero rate for products listed in decree 6.426/2008

Negative products:

  • Type of products: OTC products that fall under PL 10.147/00.
  • Single-phase regime with 2.1% PIS and 9.9% COFINS
  • This calculation is not based on lucro presumido

Neutral Products:

  • Type of products: All other consumer products
  • Multi-phase Regime with 0.65% of PIS and 3.0% of COFINS
  • Taxation is cascaded at each stage from production to distribution

Key tax reforms

  • PL 3.887/2020 – Introduction of new tax CBS
  • PEC-45/2019 – Consolidation of 5 different taxes by creating a GST.
  • PEC-110/2019 – Replacing existing 9 taxes with 2 new taxes

Current legislation

  • PL no. 10.147/00
  • PL no. 10.637/02
  • PL no. 10.833/03
  • PL no. 10.865/04
  • Non-Cumulative Tax regime rates: PIS @ 1.65% and COFINS @ 7.60%
  • Cumulative Tax regime rates: PIS @ 0.65% and COFINS @ 3.00%

Potential impact

  • Increase in tax burden by 2.75% for non-cumulative regime.
  • Cumulative regime abolished.
  • Zero rate benefit on hospital products is abolished.
  • PL 10.865/04 will be abolished.
  • Basic products (Cesta Básica) are exempted from new law.

Related solution

Finance transformation

Morbi rhoncus, nibh nec scelerisque feugiat, sapien urna dapibus rhoncus turpis.

Helixr’s strengths

Our team are experts in implementing tax technology projects in the most complex regimes of the LATAM region and will provide experience in:
  • Understanding the tax regulations and incentives that are applicable to pharmaceutical manufacturing and commercial distribution processes
  • Recognising the requirements for managing the end-to-end contract manufacturing processes in line with ICMS tax legislation for states like Rio de Janeiro and Sao Paulo
  • Understanding the requirements of the electronic nota fiscal
  • Defining systems for processes from master data standardisation and transactional processing to SPED submissions

Share:

Our expert
Meet our people
Meet our people

Phani Sabnivisu

Founder & Executive Director

More from us
View all resources
  • News

Refreshing our brand for now and the future

  • Insight

Connecting SAP HANA to Power BI: Why it matters and how to do it

  • Case Study

From internal restructuring to supply chain transformation at a global luxury skincare brand

View all resources
Join us
Connect with Helixr
Let’s have a conversation. Contact us to find out more about what we can do for you.
Contact us
Contact us

Contact

Helixr Ltd HQ

Helixr Ltd Innovation

Helixr Limited Ireland

  • +353 1 437 6901
  • Helixr, 92 George Street Lower, Dún Laoghaire, Dublin, A96 VR66, Republic of Ireland

Helixr India Private Limited

  • +91 90100 08310
  • Helixr, P.No.18/2, Sector III, HUDA Techno Enclave, Madhapur, Shaikpet, Hyderabad-500081, Telangana, India
Company
Solutions
  • ISO 9001 accreditation is for Helixr Ltd UK only
© 2025 Helixr
Contact us

Contact

Helixr Ltd HQ

Helixr Ltd Innovation

Helixr Limited Ireland

  • +353 1 437 6901
  • Helixr, 92 George Street Lower, Dún Laoghaire, Dublin, A96 VR66, Republic of Ireland

Helixr India Private Limited

  • +91 90100 08310
  • Helixr, P.No.18/2, Sector III, HUDA Techno Enclave, Madhapur, Shaikpet, Hyderabad-500081, Telangana, India
Company
Solutions
  • ISO 9001 accreditation is for Helixr Ltd UK only
© 2025 Helixr
Back

Phani Sabnivisu

Founder & Executive Director

phani.sabnivisu@helixr.com

Phani loves a new challenge. The intricate world of finance and tax functions have provided him with plenty of them over the last 25+ years. He has worked on projects in Europe and the US, and the APAC and LATAM regions, including in the most tax-complex countries like Brazil and Argentina.

Working with ERP systems, external tax engines and process automation technologies, Phani has guided many multinationals across a variety of industries to optimise their operations. His calm, dedicated and friendly manner has lead organisations through best practice, data modeling and defining the right technology for their business. 

Contact us